- Home
- CUBE vs CORT Comparison
CUBE vs CORT Comparison
Compare CUBE & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUBE
- CORT
- Stock Information
- Founded
- CUBE 2004
- CORT 1998
- Country
- CUBE United States
- CORT United States
- Employees
- CUBE N/A
- CORT N/A
- Industry
- CUBE Real Estate Investment Trusts
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- CUBE Real Estate
- CORT Health Care
- Exchange
- CUBE Nasdaq
- CORT Nasdaq
- Market Cap
- CUBE 8.1B
- CORT 7.1B
- IPO Year
- CUBE 2004
- CORT N/A
- Fundamental
- Price
- CUBE $42.65
- CORT $70.59
- Analyst Decision
- CUBE Buy
- CORT Strong Buy
- Analyst Count
- CUBE 14
- CORT 4
- Target Price
- CUBE $48.14
- CORT $142.00
- AVG Volume (30 Days)
- CUBE 1.8M
- CORT 1.4M
- Earning Date
- CUBE 05-01-2025
- CORT 05-05-2025
- Dividend Yield
- CUBE 4.89%
- CORT N/A
- EPS Growth
- CUBE N/A
- CORT 8.36
- EPS
- CUBE 1.69
- CORT 1.14
- Revenue
- CUBE $1,079,894,000.00
- CORT $685,446,000.00
- Revenue This Year
- CUBE $1.71
- CORT $35.85
- Revenue Next Year
- CUBE $3.68
- CORT $35.22
- P/E Ratio
- CUBE $25.41
- CORT $61.82
- Revenue Growth
- CUBE 1.89
- CORT 30.93
- 52 Week Low
- CUBE $34.24
- CORT $25.35
- 52 Week High
- CUBE $55.14
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- CUBE 60.76
- CORT 50.86
- Support Level
- CUBE $41.74
- CORT $69.33
- Resistance Level
- CUBE $43.08
- CORT $73.36
- Average True Range (ATR)
- CUBE 0.99
- CORT 3.66
- MACD
- CUBE 0.32
- CORT -0.20
- Stochastic Oscillator
- CUBE 81.40
- CORT 39.15
About CUBE CubeSmart
CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.